L(-)-Carnitine
 OpenBabel02212023462D

 11 10  0  0  1  0  0  0  0  0999 V2000
    1.7605    1.0164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4750    1.4289    0.0000 N   0  3  0  0  0  0  0  0  0  0  0  0
    2.8875    0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0625    2.1434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1895    1.8414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9039    1.4289    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.9039    0.6039    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6184    1.8414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3329    1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0474    1.8414    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3329    0.6039    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  2  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  1  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
M  CHG  2   2   1  11  -1
M  END
>  <CdId>
474

>  <Mol Weight>
161.1989

>  <Formula>
C7H15NO3

>  <ID>
T0846

>  <Name>
L(-)-Carnitine

>  <Synonyms>
Levocarnitine

>  <CAS>
541-15-1

>  <Approved status>
FDA

>  <Disease>
Cardiovascular system

>  <Indication>
Peripheral Arterial Occlusive Disorders

>  <Pathways>
Metabolism

>  <Target>
Fatty Acid Synthase

>  <Receptor>
FAS

$$$$
